Why the study?
Does a single 10-mg oral dose of ramipril lower blood pressure and inhibit ACE activity in hypertensive patients with impaired renal function?
Does a single 10-mg oral dose of ramipril lower blood pressure and inhibit ACE activity in hypertensive patients with impaired renal function?
A single 10-mg dose of ramipril effectively lowers blood pressure and inhibits ACE activity in hypertensive patients regardless of the degree of renal impairment, without acutely worsening serum creatinine.
Answers are grounded in this paper and cite their sources.
May support acute BP control with ramipril in renal impairment; leaves open need for RCTs on sustained efficacy and safety.
A single oral 10-mg dose of ramipril, a long-acting angiotensin converting enzyme (ACE) inhibitor, was given to 24 hypertensive patients with different degrees of renal function. Creatinine clearance ranged from below 15 ml/min (n = 9) to above 80 ml/min (n = 3). Serial blood samples were taken for the determination of ACE activity, plasma renin activity (PRA), aldosterone (ALDO), angiotensin II (AT II), and serum creatinine (CR). Blood pressure was also monitored before and after medication. After administration of ramipril systolic and diastolic blood pressure (BP) fell; the decreases were unrelated to renal function. Peak BP-lowering effect was seen at 6 h basal, 174 +/- 19.5/102.6 +/- 8.9 to 149.8 +/- 19.7/87.6 +/- 13.3 mm Hg (mean +/- SD; p less than 0.001). ACE inhibition occurred within 2 h, being maximal at 4 h: basal, 82.6 +/- 17.9 to 0.2 +/- 0.6 nmol/ml/min (p less than 0.001). The greater the renal impairment, the longer the ACE inhibition. Angiotensin II was reduced maximally at 10 h after dosing, from 10.4 +/- 5.4 to 6.2 +/- 3.6 pg/ml (p less than 0.01). Aldosterone also fell from 212 +/- 188.4 to 134 +/- 73.3 pg/ml at 6 h (p less than 0.01). Plasma creatinine was unchanged: 401.3 +/- 315.7 to 394.9 +/- 306.1 nmol/L (NS). Ramipril, given as a single oral dose, lowers BP in hypertensives with both normal and impaired renal function, inhibits ACE activity, and causes no change in serum creatinine.
No takes yet. Share an insight, caveat, or question.
Ocón-Pujadas et al. (1989) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: